Providing information to the drug discovery sector

Dedicated to Drug Discovery

LeadDiscovery was founded in 1998 by life scientists to expedite drug discovery and pharmaceutical development. Based on a solid background of experience from within the pharmaceutical research and development sector our aim is to help companies optimize drug discovery and product pipelines through the identification of breaking research and the in depth and expert evaluation of selected therapeutic areas.

At the same time we provide a showcase for pharmaceutical, biotechnology and academic organizations wishing to increase the exposure of their research to the drug development community.

We support the drug discovery and pharmaceutical development community through three key services: DailyUpdates, UpdatesPlus and PharmaReports

Todays drug discovery and development headlines from across the DailyUpdates network

9th May 2008

Drug Development News: ZIOPHARM Receives FDA Orphan Drug Designation for Palifosfamide (ZIO-201) in the Treatment of Soft Tissue Sarcoma

Headlined Journal Article: Discovery of Subnanomolar Arginine-Glycine-Aspartate-Based alphaVbeta3/alphaVbeta5 Integrin Binders Embedding 4-Aminoproline Residues.

Clinical Trials: Erlotinib and Sunitinib in NSCLC

Today’s Featured Pharmaceutical Report: Pipeline Insight: Breast Cancer

Pharmaceutical Training Courses and Meetings: Cancer Biomarkers Development and Clinical Use


LeadDiscovery recommends ClusterMed for faster discovery and automatic organization of PubMed results into categories


PharmaReports: LeadDiscovery offers in depth pharmaceutical reports on selected areas of the pharmaceutical and biotech sector. For a full list of our featured market research reports and pipeline analyses click here

Reports uploaded May 9th

Reports uploaded May 8th

Reports uploaded May 7th

Reports uploaded May 6th

Reports uploaded May 5th

Reports uploaded May 4th

Reports uploaded May 3rd